DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
ARMY BIOLOGICAL LABS FREDERICK MD
Pagination or Media Count:
The following is the entire content of the translated document The treatment of red corpuscles from new-borns with papain reveals, by Cooms technique, the anti-A or anti-B antibodies fixed in vitro or in vivo during the hemolytic disease of the new-born connected to an immunization to the A and B factors. The test proposed allows a simple and rapid diagnosis for this hemolytic disease even before the appearance of jaundice. It will allow the medical preventative treatment of the new-born by therapy whose efficiency we demonstrated earlier. Exsanguino-transfusions thus can perhaps be avoided, since the indirect bilirubin titer does not reach a menacing amount in most cases. Work will continue on finding the exact mechanism of the papain action.
APPROVED FOR PUBLIC RELEASE